Videos
Busy, modern lifestyles mean that non-compliance to prescribed medication is now universally recognised as a significant problem, leading to ineffective treatment, more frequent GP and hospital visits, life threatening situations and significantly increased costs to our healthcare system.
The Dial Vial Patient Compliance Bottle Range has been specifically developed to deliver: * A cost effective aid to to improved compliance * A simple and easy-to-use aid to improved compliance
The Dial Vial Patient Compliance Bottle Range is available in six different bottle sizes (30ml, 44ml, 60ml, 74ml, 100ml and 140ml) and 5 different dosage regimen closure options (1x daily, 2x daily, 3x daily, 4x daily and prn).
The Dial Vial range is fully compliant with the following protocols: * Child Resistant ISO 8317:2003 * Poison Prevention Packaging (CFR 1700) * Moisture Vapour Transmission Rate (MVTR)
In addition, because the Dial Vial range is the only bottle and closure range to be manufactured from a single material recyclable polypropylene, the bottle and closures do not need to be separated prior to recycling which means the Dial Vial has an excellent environmentally friendly profile.
For further information and samples on this major improvement to patient healthcare, do not hesitate to contact Neville and More on 01403 732290.
This Video is related to Patient Compliance with Diabetic Retinopathy.
Wellness Works: Medicine Adherence
Approximately one third of all prescriptions are never filled, and over half of prescriptions that are filled are not taken as prescribed in the United States. This rate of non-adherence includes patients taking drugs for serious conditions such as asthma, high blood pressure and diabetes. According to primary care physicians, the health of one in five patients is compromised by non-adherence. The consequence of poor adherence to medications is a critical issue that impacts your health and productivity. But understanding your medication can mean the difference between suffering and relief.
IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.
Journal for Clinical Studies (JCS) is a peer reviewed journal which details practical and theoretical operational procedures, challenges, validatory and regulatory guidelines when conducting trials on a multisite basis and particularly within emerging markets, naïve patient population and remote access areas. JCS provides country by country objectives and uniquely brings you experiences in therapeutic areas prevalent in emerging market areas.
